Training for Experienced Radiation Safety Officer, Teletherapy or Medical Physicist, Authorized

Medical Physicist, Authorized User, Nuclear Pharmacist, and Authorized Nuclear Pharmacist (A) (1) An individual identified on an Agency, Nuclear Regulatory Commission or Agreement State license or a permit issued by an Agency, Nuclear Regulatory Commission or Agreement State broad scope licensee or master material license permit or by a master material license permittee of broad scope as a Radiation Safety Officer, a teletherapy or medical physicist, an authorized medical physicist, a nuclear pharmacist or an authorized nuclear pharmacist on or before January 14, 2019 need not comply with the training requirements of 105 CMR 120.524, 120.525, or 120.526, respectively, except the Radiation Safety Officers and authorized medical physicists identified in 105 CMR 120.528(A)(1) must meet the training requirements in 105 CMR 120.524(D) or 120.525(C), as appropriate, for any material or uses for which they were not authorized prior to this date. (2) Any individual certified by the American Board of Health Physics in Comprehensive Health Physics; American Board of Radiology; American Board of Nuclear Medicine; American Board of Science in Nuclear Medicine; Board of Pharmaceutical Specialties in Nuclear Pharmacy; American Board of Medical Physics in radiation oncology physics; Royal College of Physicians and Surgeons of Canada in nuclear medicine; American Osteopathic Board of Radiology; or American Osteopathic Board of Nuclear Medicine on or before October 24, 2005, need not comply with the training requirements of 105 CMR 120.524 to be identified as a Radiation Safety Officer or as an Associate Radiation Safety Officer on an Agency, Nuclear Regulatory Commission or Agreement State license or Nuclear Regulatory Commission master material license permit for those materials and uses that these individuals performed on or before October 24, 2005. (3) Any individual certified by the American Board of Radiology in therapeutic radiological physics, Roentgen ray and gamma ray physics, X-ray and radium physics, or radiological physics, or certified by the American Board of Medical Physics in radiation oncology physics, on or before October 24, 2005, need not comply with the training requirements for an authorized medical physicist described in 105 CMR 120.525, for those materials and uses that these individuals performed on or before October 24, 2005. (4) A Radiation Safety Officer, a medical physicist, or a nuclear pharmacist, who used only accelerator-produced radioactive materials, discrete sources of radium-226, or both, for medical uses or in the practice of nuclear pharmacy at a Federal Government agency or Federally recognized Indian Tribe before November 30, 2007 or at all other locations of use before August 8, 2009, or an earlier date as noticed by the NRC, need not comply with the training requirements of 105 CMR 120.524, 120.525 or 120.526, respectively, when performing the same uses. A nuclear pharmacist, who prepared only radioactive drugs containing accelerator-produced radioactive materials, or a medical physicist, who used only accelerator-produced radioactive materials, at the locations and during the time period identified in 105 CMR 120.528(A)(4), qualifies as an authorized nuclear pharmacist or an authorized medical physicist, respectively, for those materials and uses performed before these dates, for the purposes of 105 CMR 120.500. (B) (1) Physicians, dentists, or podiatrists identified as authorized users for the medical use of byproduct material on a license issued by the Agency, Nuclear Regulatory Commission or an Agreement State, a permit issued by a Nuclear Regulatory Commission master material licensee, a permit issued by the Agency, Nuclear Regulatory Commission or an Agreement State broad scope licensee, or a permit issued by a Nuclear Regulatory Commission master material license broad scope permittee on or before January 14, 2019, who perform only those medical uses for which they were authorized on or before that date need not comply with the training requirements of 105 CMR 120.546, 120.551, 120.556, 120.557, 120.558, 120.558A, 120.566, 120.567, 120.569 and 120.587. (2) Physicians, dentists, or podiatrists not identified as authorized users for the medical use of byproduct material on a license issued by the Agency, Nuclear Regulatory Commission or an Agreement State, a permit issued by a Nuclear Regulatory Commission master material licensee, a permit issued by the Agency, Nuclear Regulatory Commission or an Agreement State broad scope licensee, or a permit issued by a Nuclear Regulatory Commission master material license of broad scope on or before October 24, 2005, need not comply with the training requirements of 105 CMR 120.546, 120.551, 120.556, 120.557, 120.558, 120.558A, 120.566, 120.567, 120.569 and 120.587 for those materials and uses that these individuals performed on or before October 24, 2005, as follows: (a) For uses authorized under 105 CMR 120.544 or 120.547, or oral administration of sodium iodide I–131 requiring a written directive for imaging and localization purposes, a physician who was certified on or before October 24, 2005, in nuclear medicine by the American Board of Nuclear Medicine; diagnostic radiology by the American Board of Radiology; diagnostic radiology or radiology by the American Osteopathic Board of Radiology; nuclear medicine by the Royal College of Physicians and Surgeons of Canada; or American Osteopathic Board of Nuclear Medicine in nuclear medicine; (b) For uses authorized under 105 CMR 120.552, a physician who was certified on or before October 24, 2005, by the American Board of Nuclear Medicine; the American Board of Radiology in radiology, therapeutic radiology, or radiation oncology; nuclear medicine by the Royal College of Physicians and Surgeons of Canada; or the American Osteopathic Board of Radiology after 1984; (c) For uses authorized under 105 CMR 120.559 or 120.570, a physician who was certified on or before October 24, 2005, in radiology, therapeutic radiology or radiation oncology by the American Board of Radiology; radiation oncology by the American Osteopathic Board of Radiology; radiology, with specialization in radiotherapy, as a British ‘‘Fellow of the Faculty of Radiology'' or ‘‘Fellow of the Royal College of Radiology''; or therapeutic radiology by the Canadian Royal College of Physicians and Surgeons; and (d) For uses authorized under 105 CMR 120.568, a physician who was certified on or before October 24, 2005, in radiology, diagnostic radiology, therapeutic radiology, or radiation oncology by the American Board of Radiology; nuclear medicine by the American Board of Nuclear Medicine; diagnostic radiology or radiology by the American Osteopathic Board of Radiology; or nuclear medicine by the Royal College of Physicians and Surgeons of Canada. (3) Physicians, dentists, or podiatrists who used only accelerator-produced radioactive materials, discrete sources of radium-226, or both, for medical uses performed at a Government agency or Federally recognized Indian Tribe before November 30, 2007, or at all other locations of use before August 8, 2009, or an earlier date as noticed by the NRC, need not comply with the training requirements of 105 CMR 120.546, 120.551, 120.556, 120.557, 120.558, 120.558A, 120.566, 120.567, 120.569 and 120.587 when performing the same medical uses. A physician, dentist, or podiatrist, who used only accelerator-produced radioactive materials, discrete sources of radium-226, or both, for medical uses at the locations and time period identified in 105 CMR 120.528(B)(3), qualifies as an authorized user for those materials and uses performed before these dates, for the purposes of 105 CMR 120.500. (C) Individuals who need not comply with training requirements as described in 105 CMR 120.528 may serve as preceptors for, and supervisors of, applicants seeking authorization on Agency licenses for the same uses for which these individuals are authorized.